학술논문
WS16.02 Real-world (RW) clinical effectiveness of elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) in children with cystic fibrosis aged 6–11 years: interim results from the HELIO study
Document Type
Abstract
Author
Source
In Journal of Cystic Fibrosis June 2023 22 Supplement 2:S30-S30
Subject
Language
ISSN
1569-1993